
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES127
An RCT258 comparing therapy with valsartan and amlodipine reported results for a prespecified
subgroup of Type 2 diabetes patients and found non-significant differences between
the two treatment arms for the primary composite cardiac outcome which looked at cardiac
mortality and morbidity.* Level 1+

[@Holzgreve_2003]

